We would like to congratulate Jane Harmer as this month she has celebrated achieving 40 years in the Personal Care Industry. Jane is Associate Director Product Development at UPL and her current role incorporates both product and business development responsibilities which draws on her 40 years of valuable experience.
Since her early days in the 1970’s in the toiletry development labs at Reckitt & Colman through to her time both forming and running Harmer Personal Care, she has maintained her love of developing new products and working with customers to identify ways to expand and improve the personal care sector.
As a qualified chemist and Member of the Society of Cosmetic Scientists Jane has technical knowledge as well as commercial experience which gives her a unique perspective for her role as Associate Director of Product Development at UPL.
Congratulations once again to Jane on this great achievement.
We have a number of new starters at UPL and we would like to welcome them to the team:
We are strengthening the Pack Tech Dept with the recruitment of Alex Tate who joined the team on Monday 2nd July.
Alex has a wealth of industry experience having previously worked in the packaging departments of Body Shop, Boots, Tesco and Unilever and she is a very welcome addition to the UPL team.
We are also pleased to announce the full time appointment of Kirsty Wolstenholme to the Customer Services team. Kirsty’s appointment will strengthen and enhance the service and support that we give to our Customers and we all wish her well in her new role.
Alongside our new starters we also have some established and valued employees who are now retiring:
Barry Thornber has recently retired from the manufacturing department after nearly 21 years with UPL. However he will still continue with the voluntary work he has done for the HM coast guard for the past 36 years.
We would like to thank him for his hard work and wish him well for the future.
UPL recently completed a routine MHRA inspection involving 2 inspectors over 3 days. This was the 30 month inspection as determined by the risk based assessment process. The inspection examined the UPL quality management system, operation and facilities for compliance with the required GMP standard.
For the second consecutive inspection UPL had a successful outcome with no Critical or Major non compliances. The success of the inspection reinforces the commitment to the safety, quality and efficacy of the medicines manufactured at UPL.